Drug Trial Radar · NCT05748600
A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Eosinophilic Asthma
Last checked: Nov 19, 2026Latest source record: Sep 5, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
600
Planned (sponsor's estimate)
Start
Jan 30, 2023
Primary completion
Sep 2025
Study completion Dec 2025
Sponsor
- Lead sponsor
- Areteia TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Feb 28, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 99 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma to evaluate improvements in lung function, asthma control, and quality of life. In addition, the study will further evaluate the safety and tolerability of dexpramipexole in participants with eosinophilic asthma.
Conditions
- Eosinophilic Asthma
- Asthma; Eosinophilic
- Asthma Attack
Interventions
Dexpramipexole DihydrochlorideDrug
administration of dexpramipexole tablet
PlaceboDrug
administration of placebo tablet
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in pre-BD FEV₁ from baselineTime frame: Day 1 (baseline, pre-dose), Weeks 20, 24
Locations
335 sites in 18 countries. Site status is shown where the registry gives one.
Research Site 40001-487
Chandler, Arizona
Research Site 40001-462
Peoria, Arizona
Research Site 40001-322
Surprise, Arizona
Research Site 40001-374
Bakersfield, California
Research Site 40001-227
Encinitas, California
Research Site 40001-349
Huntington Beach, California
Research Site 40001-485
Inglewood, California
Research Site 40001-440
La Palma, California
Research Site 40001-357
Lancaster, California
Research Site 40001-089
Los Angeles, California
Research Site 40001-362
Mission Viejo, California
Research Site 40001-449
Napa, California
Research Site 40001-062
Newport Beach, California
Research Site 40001-043
Newport Beach, California
Research Site 40001-380
Redding, California
Research Site 40001-434
San Diego, California
Research Site 40001-088
San Jose, California
Research Site 40001-359
Upland, California
Research Site 40001-003
West Covina, California
Research Site 40001-419
Westminster, California
Research Site 40001-425
Aurora, Colorado
Research Site 40001-353
Colorado Springs, Colorado
Research Site 40001-385
Wheat Ridge, Colorado
Research Site 40001-048
Aventura, Florida
Research Site 40001-005
Brandon, Florida
Research Site 40001-051
Brandon, Florida
Research Site 40001-029
Coral Gables, Florida
Research Site 40001-350
Gainesville, Florida
Research Site 40001-014
Greenacres City, Florida
Research Site 40001-054
Hialeah, Florida
Research Site 40001-067
Hialeah, Florida
Research Site 40001-020
Homestead, Florida
Research Site 40001-015
Kissimmee, Florida
Research Site 40001-002
Kissimmee, Florida
Research Site 40001-086
Loxahatchee Groves, Florida
Research Site 40001-318
Maitland, Florida
Research Site 40001-066
Miami, Florida
Research Site 40001-001
Miami, Florida
Research Site 40001-059
Miami, Florida
Research Site 40001-026
Miami, Florida
Showing 40 of 335 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.